Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1998 2
2003 2
2004 4
2005 2
2006 5
2007 5
2008 5
2009 9
2010 11
2011 15
2012 16
2013 12
2014 8
2015 16
2016 24
2017 13
2018 30
2019 49
2020 79
2021 92
2022 117
2023 126
2024 131
2025 148
2026 75

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

877 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Cannabidiol in Inflammation: A Review of Pre-clinical and Clinical Findings.
Sklenárová M, Šíma M, Slanař O. Sklenárová M, et al. Prague Med Rep. 2023;124(3):216-229. doi: 10.14712/23362936.2023.17. Prague Med Rep. 2023. PMID: 37736946 Free article. Review.
Cannabidiol (CBD) is the second most abundant component of the plant Cannabis sativa. Currently, CBD is approved for Lennox-Gastaut and Dravet syndrome and newly for tuberous sclerosis complex. ...The medical keyword term "cannabidiol" was combined with "pain", "art …
Cannabidiol (CBD) is the second most abundant component of the plant Cannabis sativa. Currently, CBD is approved for Lennox-Gastaut a …
Cannabidiol: pharmacology and therapeutic targets.
Britch SC, Babalonis S, Walsh SL. Britch SC, et al. Psychopharmacology (Berl). 2021 Jan;238(1):9-28. doi: 10.1007/s00213-020-05712-8. Epub 2020 Nov 21. Psychopharmacology (Berl). 2021. PMID: 33221931 Free PMC article. Review.
RATIONALE: Cannabidiol (CBD) products lacking regulatory approval are being used to self-treat a myriad of conditions and for their unsubstantiated health benefits. ...OBJECTIVES: This paper reviews the molecular targets, pharmacokinetics, and safety and abuse liability of …
RATIONALE: Cannabidiol (CBD) products lacking regulatory approval are being used to self-treat a myriad of conditions and for their u …
Cannabidiol as a possible treatment for endometriosis through suppression of inflammation and angiogenesis.
Anvari Aliabad R, Hassanpour K, Norooznezhad AH. Anvari Aliabad R, et al. Immun Inflamm Dis. 2024 Aug;12(8):e1370. doi: 10.1002/iid3.1370. Immun Inflamm Dis. 2024. PMID: 39110084 Free PMC article. Review.
OBJECTIVE: This review aims to explore the role of inflammation and angiogenesis in endometriosis and suggest a potential treatment targeting these pathways. ...Cannabidiol (CBD) is a non-psychoactive member of cannabinoids which has well-known and notable anti-infl …
OBJECTIVE: This review aims to explore the role of inflammation and angiogenesis in endometriosis and suggest a potential treatment t …
Scientific Validation of Cannabidiol for Management of Dog and Cat Diseases.
Corsato Alvarenga I, Panickar KS, Hess H, McGrath S. Corsato Alvarenga I, et al. Annu Rev Anim Biosci. 2023 Feb 15;11:227-246. doi: 10.1146/annurev-animal-081122-070236. Annu Rev Anim Biosci. 2023. PMID: 36790884 Free article. Review.
Cannabidiol (CBD) is a non-psychotropic phytocannabinoid of the plant Cannabis sativa L. ...
Cannabidiol (CBD) is a non-psychotropic phytocannabinoid of the plant Cannabis sativa L. ...
Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
Golub V, Reddy DS. Golub V, et al. Adv Exp Med Biol. 2021;1264:93-110. doi: 10.1007/978-3-030-57369-0_7. Adv Exp Med Biol. 2021. PMID: 33332006 Review.
Recently, there has been emerging interest in the use of cannabidiol (CBD)-enriched products for treatment of drug-resistant epilepsy. In 2018, the FDA approved the use of CBD-rich Epidiolex for two severe forms of epilepsy in children (Lennox-Gastaut and Dravet syndromes) …
Recently, there has been emerging interest in the use of cannabidiol (CBD)-enriched products for treatment of drug-resistant epilepsy …
PPARG-mediated autophagy activation alleviates inflammation in rheumatoid arthritis.
Geng Q, Xu J, Cao X, Wang Z, Jiao Y, Diao W, Wang X, Wang Z, Zhang M, Zhao L, Yang L, Deng T, Fan B, Xu Y, Jia L, Xiao C. Geng Q, et al. J Autoimmun. 2024 Jun;146:103214. doi: 10.1016/j.jaut.2024.103214. Epub 2024 Apr 21. J Autoimmun. 2024. PMID: 38648706
INTRODUCTION: Rheumatoid arthritis (RA) is a systemic inflammatory autoimmune disease characterized by joint inflammation and bone damage, that not only restricts patient activity but also tends to be accompanied by a series of complications, seriously affecting patient pr …
INTRODUCTION: Rheumatoid arthritis (RA) is a systemic inflammatory autoimmune disease characterized by joint inflammation and bone da …
Molecular and Cellular Mechanisms of Action of Cannabidiol.
Martinez Naya N, Kelly J, Corna G, Golino M, Abbate A, Toldo S. Martinez Naya N, et al. Molecules. 2023 Aug 9;28(16):5980. doi: 10.3390/molecules28165980. Molecules. 2023. PMID: 37630232 Free PMC article. Review.
Cannabidiol (CBD) is the primary non-psychoactive chemical from Cannabis Sativa, a plant used for centuries for both recreational and medicinal purposes. ...CBD exerts a wide spectrum of effects at a molecular, cellular, and organ level, affecting inflammation, oxid …
Cannabidiol (CBD) is the primary non-psychoactive chemical from Cannabis Sativa, a plant used for centuries for both recreational and …
Inflammation-targeted cannabidiol-loaded nanomicelles for enhanced oral mucositis treatment.
Liu Y, Qi X, Wang Y, Li M, Yuan Q, Zhao Z. Liu Y, et al. Drug Deliv. 2022 Dec;29(1):1272-1281. doi: 10.1080/10717544.2022.2027572. Drug Deliv. 2022. PMID: 35467472 Free PMC article.
In this study, we used deoxycholic acid and fucoidan to prepare inflammation-targeting nanomicelles (FD), because fucoidan can target inflammation due to its high binding affinity for P-selectin. The hydrophobic anti-inflammatory drug cannabidiol (CBD) was th …
In this study, we used deoxycholic acid and fucoidan to prepare inflammation-targeting nanomicelles (FD), because fucoidan can target …
Assessing Cannabidiol as a Therapeutic Agent for Preventing and Alleviating Alzheimer's Disease Neurodegeneration.
Chen L, Sun Y, Li J, Liu S, Ding H, Wang G, Li X. Chen L, et al. Cells. 2023 Nov 21;12(23):2672. doi: 10.3390/cells12232672. Cells. 2023. PMID: 38067101 Free PMC article.
Neuroinflammation, which is central to AD's pathology, results in synaptic and neuronal damage, highlighting the importance of addressing inflammation and conserving neuronal integrity. Cannabidiol (CBD), derived from cannabis, is noted for its neuroprotective and a …
Neuroinflammation, which is central to AD's pathology, results in synaptic and neuronal damage, highlighting the importance of addressing …
877 results